CASI Pharmaceuticals, Inc. (36) | Uncategorized (6)
Recent Contracts
-
Exhibit 1.1Underwriting Agreement, dated March 24, 2021, between CASI and Oppenheimer & Co. Inc
(Filed With SEC on March 26, 2021)
-
Exhibit 1.1Underwriting Agreement dated July 22, 2020, between the Company and Oppenheimer & Co. Inc
(Filed With SEC on July 24, 2020)
-
Open Market Sale AgreementSM by and between CASI Pharmaceuticals, Inc. and Jefferies LLC dated July 19, 2019
(Filed With SEC on July 19, 2019)
-
Offer Letter from CASI Pharmaceuticals, Inc. to Dr. He dated March 22, 2019, effective April 2, 2019
(Filed With SEC on May 15, 2019)
-
Offer Letter from CASI Pharmaceuticals, Inc. to Dr. He dated March 22, 2019, effective April 2, 2019
(Filed With SEC on May 15, 2019)
-
Labor Contract, effective as of September 1, 2018, between CASI (Beijing) Pharmaceuticals, Inc. and Wei (Larry) Zhang
(Filed With SEC on March 29, 2019)